November 18, 2020

Seroprevalence of SARS-CoV-2 in slums versus non-slums in Mumbai, India (The Lancet)

By Sofia Imad, Anup Malani, Manoj Mohanan, Sachee Agrawal, Gagandeep Kang, Ullas Kolthur-Seetharam, Rajesh Jain, Sandeep Juneja, Gayatri Nair Lobo, Daksha Shah, Jayanthi Shastri

Sero-surveillance provides estimates of antibody levels against infectious diseases and is considered the gold standard for measuring population immunity due to past infection or vaccination. This research estimates the seroprevalence of SARS CoV-2 (causing COVID-19) in slum and non-slum areas of Mumbai in July 2020. These results are instrumental in understanding the dynamics of transmission in the city and informing the design of appropriate public health policies.


The paper was published in the Lancet Global Health. A preprint of the study is available here.

View this Publication
( LINK TO External Website )
x Close Window

Please verify your email address to access this content